Jump to Navigation

Antipsychotic Roundup 2007

March, 2007 | Vol: 5 Issue: 3

In this issue

Learning Objective

Learning Objectives, March 2007

This CME activity is intended for psychiatrists, psychiatric nurses, and other health-care professionals with an interest in the diagnosis and treatment
of psychiatric disorders.

Article

Invega: Can You Say "Patent Extender?"

Janssen’s marketing team apparently missed the fact that the word in the English language that sounds most like “Invega” is “inveigle,” meaning “to entice, lure, or ensnare by flattery or artful talk or inducements” (www.dictionary.com). You may have already heard some “artful talk” from your Janssen reps, who are keen to have you convert your patients from Risperdal to Invega. Will you be doing your patients a favor by taking the plunge? Or will you simply be giving them the same wine in a fancier bottle?

Do Second-Generation Antipsychotics Treat Depression? An Update

In this article, guest author Dr. Shalom Feinberg, takes a hard look at the most recent data on the effectiveness of SGAs for depression in its various guises, including treatment-resistant depression (TRD) and bipolar depression (BD).

Expert QA

Research Update